Background: Hepatocyte to biliary transdifferentiation has been documented in various models
INTRODUCTION
Transdifferentiation, also known as lineage reprogramming, is a process where one mature somatic cell transforms into another mature somatic cell without undergoing an intermediate pluripotent state 1 . Hepatocyte to biliary transdifferentiation (HBT) is activated when there is extensive loss of functional biliary cells, and the resident biliary cells are unable/insufficient to proliferate to compensate for the loss. Under such situations, hepatocytes can transdifferentiate to biliary cells and help regenerate the bile ducts [2] [3] [4] . There is now growing evidence for this pathway, and current and future studies in this area are geared toward identifying the mechanisms and drivers that bring about this change. In recent years, many efforts have been aimed at generating pluripotent stem cells from somatic cells by inducing high expression of a combination of transcription (reprogramming) factors including Sox2, Octamer binding protein 4 (Oct4), Nanog, Klf4, and cMyc [5] [6] [7] . While these reprogramming factors are expressed in stem cells, their expression in adult somatic cells with high potential for clonal expansion such as hepatocytes has been less explored. Our previous study has documented that adult rat liver expresses some of these reprogramming factors in hepatocytes and biliary cells during liver regeneration and hepatocyte proliferation 8 . We further demonstrated that inhibition of these reprogramming factors affects the survival and proliferation of hepatocytes in culture. Oct4 has been previously shown to be involved with cellular reprogramming in mammalian embyogenesis 9, 10 . High expression of Oct4 is also associated with dedifferentiation of somatic cells in prostrate 11 and breast 12 tumorigenesis. However, whether Oct4 is involved in HBT (a process involving somatic cell reprogramming) is not known and is the objective of the present study. We chose the in vitro organoid culture model of HBT for this purpose due to ease of mechanistic intervention. Primary hepatocytes, when cultured in roller bottles with chemically GE-000565 Gene Expression: The Journal of Liver Research early e-pub; provisional acceptance December 4, 2017 defined Hepatocyte Growth Medium (HGM) 13 
MATERIALS AND METHODS

Organoid cultures
Male Fisher 344 rats (150-200 g) were purchased from Charles River Laboratories (Fredrick, MD). Animals were allowed food and water ad libitum. All animals received humane care
according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences and our institute. Hepatocytes were isolated by adaptation of the calcium two step collagenase perfusion technique as previously described 13, 31 .
Freshly isolated hepatocytes were added to roller bottles (850 cm 2 surface) obtained from Falcon (Franklin Lakes, NJ). Each bottle contained 210,000,000 freshly isolated hepatocytes in 250 ml of Hepatocyte Growth Medium (HGM) medium1 supplemented with HGF (20 ng/ml) and EGF (10 ng/m). The bottles were rotated at a rate of 2.5 rotations per minute and kept in an incubator maintained at 37°C, saturated humidity, and 5% CO2. The composition of HGM is described previously 15 . Organoid culture tissue was harvested on days 3, 6, 10, 15, and 21 for immunohistochemistry as well as mRNA and protein extraction for further analysis.
Total RNA extraction
Total RNA was extracted from plated cells according to the manufacturer's protocol using the RNA Bee reagent (Invitrogen, Carlsbad, USA). The isolated RNA was treated with Turbo DNAfree (Ambion, Austin, TX) according to the manufacturer's instructions. RNA was quantified by GE-000565 Gene Expression: The Journal of Liver Research early e-pub; provisional acceptance December 4, 2017 spectrophotometry at 260 nm, and purity was assessed by optical density 260/280 ratio. The RNA was stored at −80°C.
cDNA synthesis
Five micrograms RNA per sample was reverse transcribed using random hexamer to cDNA by using SuperScriptIII reverse transcriptase (Invitrogen, CA) according to the manufacturer's protocol. A no reverse transcriptase (RT) control was also included.
Real time RTPCR
Gene-specific primers used for rat were obtained from SuperArray Biosciences Corporation as follows: Gapdh (PPR06557B), Oct4 (PPR59727A), HNF-4α (PPR49773A), HNF-1β
(PPR47971A), Notch2 (PPR51608A), Hes1 (PPR46895C), Yap1 (PPR54845A). Expression levels were determined by quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) using SYBR green, and levels were normalized relative to expression of Gapdh in each sample. Fold change in gene expression was calculated by using the 2 (−ΔΔCt) method 32 .
Reverse transcribed samples were amplified in parallel on an ABI prism 7000 SDS instrument (Applied Biosystems, Foster city, CA). qRT-PCR for each sample was performed in triplicate in a 20 μl reaction with 50 ng of cDNA, 5 picomoles of each primer, and 1X SYBR green PCR mix (Qiagen # 330510). The standard conditions for real time PCR were as follows: 2 minutes at 50°C, 10 minutes at 95°C followed by 40 cycles of 15 seconds denaturation at 95°C, and elongation at 60°C for 45 seconds. A dissociation curve analysis was performed at the end of every run. A no RT and a no template control were also included in every run. PCR products were resolved on 2% agarose gels and visualized with GelRed™ Nucleic Acid Gel Stain.
Oct4 inhibition studies
Adenovirus containing shRNA for Oct4 was made at the University of Pittsburgh virus core facility. Short hairpin RNA (shRNA) targeting rat Oct4 was cloned in the BamH1-kpn1 site of adenovirus shuttle vector under the control of the human H1 promoter with enhanced green fluorescent protein (eGFP) marker. Appropriate scrambled shRNA negative controls were also included. We confirmed authenticity of the clones by digesting with Sfi 1 enzyme and sequencing (M13 Forward). Oraganoid cultures were treated with either adenovirus containing scramble shRNA (AD-Scr, control) or Oct4 shRNA (AD-Oct4). Knock down efficiency of target genes was confirmed by transfecting primary mouse hepatocytes using standard protocols. MOI of 5 was determined to be optimal for infection of primary hepatocytes based on pilot studies.
Tissue was collected on day 21.
Rat Oct4 target sequence used was as follows:
Forward oligo:
5' GATCC GAACCGTGTGAGGTGGAAC TCAAGAG GTTCCACCTCACACGGTTC TT TTTT GGTAC 3'
Reverse oligo:
Protein levels in nuclear extracts were assessed by harvesting cells from day 21 organoid cultures treated with AD-Scr and AD-Oct4. Nuclear extracts were prepared using NE-PER Nuclear and cytoplasmic extraction kit according to manufacturer's protocol (Pierce 
Immunohistochemistry on organoid culture tissues
Paraffin-embedded tissue sections (4 μm thick) were used for H&E, as well as immunohistochemical staining. Antigen retrieval was achieved by heating the slides in the microwave at high power in 1×citrate buffer for 10 minutes. The tissue sections were blocked in blue blocker for 20 minutes followed by incubation with primary antibody overnight at 4°C. The primary antibody was then linked to biotinylated secondary antibody followed by routine avidin biotin complex method. Diaminobenzidine was used as the chromogen, which resulted in a brown reaction product. Primary antibodies used were as follows: Oct4 (ab27985, 1:100), HNF-4α (R&D H1415, 1:500), HNF-1β (SC7411, 1:250).
Statistical evaluation. The statistical analysis was performed using SPSS v22 (IBM corp., Chicago, IL, USA). The data were analyzed using repeated measures one way analysis of variance (RMANOVA) for time course studies and independent Student's t-test for Oct4 inhibition studies. The results are expressed as means ± SEM obtained from three independent experiments. p≤0.05 was considered as statistically significant and p≤0.001 as highly significant. This is denoted as *p≤0.05, **p≤0.01, and ***p≤0.001.
RESULTS
Organization of organoid cultures
H&E stain: The organoid cultures were started with freshly isolated hepatocytes following liver perfusion. Tissue samples collected over a time course of 21 days exhibited the following development ( Fig.1 ): At day 3, the hepatocytes formed small islands in a random fashion. Over for HNF-1β indicating their commitment to hepatocytic phenotype (Fig.2, thick arrows) .
Oct 4 is induced during transdifferentiation
To determine if Oct4 is induced in hepatocytes during transdifferentiation, Oct4 expression was measured at mRNA and protein level over a time course in organoid cultures (Fig.3 ).
Immunohistochemical staining indicated numerous Oct4 positive nuclei at day 6 ( Fig.3A) scattered throughout the tissue. By day 10 and 15, the staining pattern became more distinct with nuclei in the surface layer (potential biliary cells, thin arrows) staining stronger than nuclei in the intermediate layer (that remain hepatocytes). Some nuclei remained negative for Oct4 indicating their commitment to hepatocytic phenotype. By day 21, the newly formed biliary cells that underwent transdifferentiation stained strongly for Oct4 (thin arrows), whereas the hepatocyte nuclei in the intermediate layer that did not transdifferentiate were negative (thick arrows). Oct4 was also significantly induced as early as 6 days in cultures when compared to day 3 ( Fig.3B-C) , and remained elevated through day 21 in cultures. Oct4 expression also exhibited two waves of induction, first at day 6 and second at day 15.
Biliary markers and precursors are induced during HBT
Biliary specific nuclear factor HNF-1β was significantly induced starting at day 6 and remained elevated through day 21 in cultures ( Fig.4A ). This corroborates with generation of biliary phenotype in this model (Fig.2) . Sox9, which is shown to be a biliary precursor/marker increased significantly on day 6 as compared to day 3 and remained elevated through day 21 in cultures GE-000565 Gene Expression: The Journal of Liver Research early e-pub; provisional acceptance December 4, 2017 (Fig.4B) . Biphenotypic marker Afp expression was significantly induced at day 10 in culture as compared to day 3 and remained induced through day 21 (Fig.4C ).
LGR5 and OV6 were assessed but were not detectable in our model. Bile acid receptor Fxr was induced significantly on day 10 and came back to day 3 levels by day 15 (Fig.4D) .
Oct4 inhibition studies
Oct4 was inhibited using adenovirus containing shRNA for Oct4 (AD-Oct4) or scramble controls (AD-Scr) as per Fig.5A . Transfection of hepatocyte cultures led to 70% transfection as assessed by eGFP through day 14 in culture without significant toxicity (Fig.5B) . Tissue samples from culture were collected at day 21 for all assessments following OCT4 inhibition. We observed the following: Oct4 expression: Oct4 mRNA (Fig.5C ) and protein (ELISA) (Fig.5D ) on day 21 was significantly lower in AD-Oct4 group as compared to AD-Scr group indicating that Oct4 was successfully inhibited using our experimental protocol. Biliary specific markers HNF-1β and CK19 were significantly downregulated in the AD-Oct4 group as compared to AD-Scr controls (Fig.5E, G) . At the same time, there were no significant differences in hepatocyte specific marker HNF-4α expression between the AD-Scr and AD-Oct4 group, suggesting that Oct4 inhibition did not negatively affect the hepatocytes (Fig.5F ). Decreased biliary marker expression was further corroborated by HNF-1β staining pattern. While AD-Scr group exhibited abundant HNF-1β positive biliary cells at the surface layer of cultures (Fig.6A-C , thin arrows), such cells were very scarce in the AD-Oct4 group (Fig. 6D-F) . Moreover, the staining intensity was also lower in Oct4 inhibited group. We did observe, however, that the cells at the surface of the organoid culture in AD-Oct4 group, even though mostly negative for HNF1β, were smaller than hepatocytes with an intermediate morphology (Fig.6D-F, thick arrows) . Most of these HNF-1β negative cells turned out to be positive for hepatocyte specific HNF-4α (Fig. 7C-D) , GE-000565 Gene Expression: The Journal of Liver Research early e-pub; provisional acceptance December 4, 2017 suggesting that these cells were not able to complete their transition from hepatocyte to biliary phenotype. On the contrary, surface layer cells of AD-Scr cultures were negative for HNF-4α staining ( Fig. 7 A-B , thick arrows) suggesting their successful transition to biliary lineage.
Hepatocytes and biliary cells were counted in tissue sections stained for HNF-1β before and after Oct4 inhibition in oraganoid culture. The following criteria were used for identification of cells:
Hepatocytes: HNF-1β negative (blue) big round nuclei. Biliary cells: HNF-1β positive (brown) small cuboidal shaped nuclei. One ribbon of organoid culture tissue was considered as one unit.
Number of hepatocytes and biliary cells in each unit were counted. Over 100 such ribbons were assessed from AD-Scr and AD-Oct4 treatment groups. Following Oct4 inhibition, there was a significant decrease in biliary to hepatocyte cell ratio as compared to AD-Scr controls (Fig.7E ).
The total number of hepatocytes between the two groups was comparable (Fig.7F) indicating that Oct4 inhibition did not affect the viability of hepatocytes that might have led to decreased biliary cells.
Previous studies have associated Notch signaling with generation of biliary phenotype. For this reason, we assessed the levels of Notch1 and Notch2 in our model. Both of these were significantly downregulated in AD-Oct4 group as compared to AD-Scr controls (Fig.8A-B, F) .
Sox9 (precursor for biliary phenotype) was significantly downregulated in Oct4 inhibited group as compared to control (Fig.8C, F) . Yap1 signaling was also downregulated in Oct4 inhibited group (Fig.8D, F) . Hes1, previously shown to be required for conversion of hepatocyte to biliary phenotype, was also downregulated by Oct4 inhibition (Fig.8E, F) .
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DISCUSSION
Our results indicate that Oct4 plays an important role in HBT. In our study, Oct4 expression is induced starting at day 6 in this HBT model. This is also the time point when some cells start expressing biliary marker HNF-1β in this model 14 (Fig.2, D6 ). This induction is seen in many (Fig. 6, 7E ) at the end of the study as assessed by biliary specific markers HNF-1β and CK19 (Fig.5E, G) . In our study, the first wave of Oct4 induction is seen around day 6, followed by a much stronger expression again at day 15 ( Fig.3B-C ). This could be attributed to previous studies showing that too little or too much Oct4 expression leads to differentiation of cells 33 . It is possible that the second wave of Oct4 induction at day 15 in our study could drive differentiation and maturation of new biliary cells derived from hepatocytes. The expression of bile acid receptor Fxr in this model is interesting. Fxr receptor expression was significantly induced at day 10 in organoid culture (Fig.4D ). This could be in response to high extracellular bile acid levels in the media generated by hepatocytes. Since increase in Fxr provides negative feedback for bile synthesis, this finding 
